Literature DB >> 21454703

Heme interacts with c1q and inhibits the classical complement pathway.

Lubka T Roumenina1, Maria Radanova, Boris P Atanasov, Krastio T Popov, Srinivas V Kaveri, Sébastien Lacroix-Desmazes, Véronique Frémeaux-Bacchi, Jordan D Dimitrov.   

Abstract

C1q is the recognition subunit of the first component of the classical complement pathway. It participates in clearance of immune complexes and apoptotic cells as well as in defense against pathogens. Inappropriate activation of the complement contributes to cellular and tissue damage in different pathologies, urging the need for the development of therapeutic agents that are able to inhibit the complement system. In this study, we report heme as an inhibitor of C1q. Exposure of C1q to heme significantly reduced the activation of the classical complement pathway, mediated by C-reactive protein (CRP) and IgG. Interaction analyses revealed that heme reduces the binding of C1q to CRP and IgG. Furthermore, we demonstrated that the inhibition of C1q interactions results from a direct binding of heme to C1q. Formation of complex of heme with C1q caused changes in the mechanism of recognition of IgG and CRP. Taken together, our data suggest that heme is a natural negative regulator of the classical complement pathway at the level of C1q. Heme may play a role at sites of excessive tissue damage and hemolysis where large amounts of free heme are released.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454703      PMCID: PMC3091251          DOI: 10.1074/jbc.M110.206136

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Specific inhibition of the classical complement pathway by C1q-binding peptides.

Authors:  A Roos; A J Nauta; D Broers; M C Faber-Krol; L A Trouw; J W Drijfhout; M R Daha
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

Review 2.  Therapeutic inhibition of the early phase of complement activation.

Authors:  Anja Roos; Tamara H Ramwadhdoebé; Alma J Nauta; C Erik Hack; Mohamed R Daha
Journal:  Immunobiology       Date:  2002-09       Impact factor: 3.144

3.  Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions.

Authors:  Jordan D Dimitrov; Lubka T Roumenina; Virjinia R Doltchinkova; Nikolina M Mihaylova; Sebastien Lacroix-Desmazes; Srinivas V Kaveri; Tchavdar L Vassilev
Journal:  J Biol Chem       Date:  2007-07-18       Impact factor: 5.157

4.  Targeting C-reactive protein for the treatment of cardiovascular disease.

Authors:  Mark B Pepys; Gideon M Hirschfield; Glenys A Tennent; J Ruth Gallimore; Melvyn C Kahan; Vittorio Bellotti; Philip N Hawkins; Rebecca M Myers; Martin D Smith; Alessandra Polara; Alexander J A Cobb; Steven V Ley; J Andrew Aquilina; Carol V Robinson; Isam Sharif; Gillian A Gray; Caroline A Sabin; Michelle C Jenvey; Simon E Kolstoe; Darren Thompson; Stephen P Wood
Journal:  Nature       Date:  2006-04-27       Impact factor: 49.962

5.  A unique property of a plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogen.

Authors:  D K Galanakis; B Ghebrehiwet
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

6.  Iron ions and haeme modulate the binding properties of complement subcomponent C1q and of immunoglobulins.

Authors:  J D Dimitrov; L T Roumenina; V R Doltchinkova; T L Vassilev
Journal:  Scand J Immunol       Date:  2007-03       Impact factor: 3.487

7.  The interaction of the factor VIII/von Willebrand factor complex with hematin.

Authors:  D Green; F H Furby; M C Berndt
Journal:  Thromb Haemost       Date:  1986-12-15       Impact factor: 5.249

Review 8.  Pattern recognition by pentraxins.

Authors:  Alok Agrawal; Prem Prakash Singh; Barbara Bottazzi; Cecilia Garlanda; Alberto Mantovani
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

9.  Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.

Authors:  Steffen U Eisenhardt; Jonathon Habersberger; Andrew Murphy; Yung-Chih Chen; Kevin J Woollard; Nicole Bassler; Hongwei Qian; Constantin von Zur Muhlen; Christoph E Hagemeyer; Ingo Ahrens; Jaye Chin-Dusting; Alex Bobik; Karlheinz Peter
Journal:  Circ Res       Date:  2009-06-11       Impact factor: 17.367

10.  Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement.

Authors:  M R Weiser; J P Williams; F D Moore; L Kobzik; M Ma; H B Hechtman; M C Carroll
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  17 in total

1.  Prevalence and gene characteristics of antibodies with cofactor-induced HIV-1 specificity.

Authors:  Maxime Lecerf; Tobias Scheel; Anastas D Pashov; Annaelle Jarossay; Delphine Ohayon; Cyril Planchais; Stephane Mesnage; Claudia Berek; Srinivas V Kaveri; Sébastien Lacroix-Desmazes; Jordan D Dimitrov
Journal:  J Biol Chem       Date:  2015-01-06       Impact factor: 5.157

2.  P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4/heme-dependent manner.

Authors:  Nicolas S Merle; Romain Paule; Juliette Leon; Marie Daugan; Tania Robe-Rybkine; Victoria Poillerat; Carine Torset; Véronique Frémeaux-Bacchi; Jordan D Dimitrov; Lubka T Roumenina
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-08       Impact factor: 11.205

3.  Complement Component C5 and TLR Molecule CD14 Mediate Heme-Induced Thromboinflammation in Human Blood.

Authors:  Anub M Thomas; Alexandra Gerogianni; Martin B McAdam; Yngvar Fløisand; Corinna Lau; Terje Espevik; Per H Nilsson; Tom Eirik Mollnes; Andreas Barratt-Due
Journal:  J Immunol       Date:  2019-08-14       Impact factor: 5.422

Review 4.  Complement inhibitors to treat IgM-mediated autoimmune hemolysis.

Authors:  Diana Wouters; Sacha Zeerleder
Journal:  Haematologica       Date:  2015-11       Impact factor: 9.941

5.  Autoantibodies against Linear Epitopes of Myeloperoxidase in Anti-Glomerular Basement Membrane Disease.

Authors:  Jian-Nan Li; Zhao Cui; Jia Wang; Shui-Yi Hu; Xiao-Yu Jia; Zhe Guan; Min Chen; Can Xie; Ming-Hui Zhao
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-26       Impact factor: 8.237

6.  Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease.

Authors:  Satheesh Chonat; Maa-Ohui Quarmyne; Caroline M Bennett; Christina L Dean; Clinton H Joiner; Ross M Fasano; Sean R Stowell
Journal:  Haematologica       Date:  2018-05-24       Impact factor: 11.047

Review 7.  Complement System Part I - Molecular Mechanisms of Activation and Regulation.

Authors:  Nicolas S Merle; Sarah Elizabeth Church; Veronique Fremeaux-Bacchi; Lubka T Roumenina
Journal:  Front Immunol       Date:  2015-06-02       Impact factor: 7.561

Review 8.  Extra-renal manifestations of complement-mediated thrombotic microangiopathies.

Authors:  Johannes Hofer; Alejandra Rosales; Caroline Fischer; Thomas Giner
Journal:  Front Pediatr       Date:  2014-09-08       Impact factor: 3.418

9.  The human c1q globular domain: structure and recognition of non-immune self ligands.

Authors:  Christine Gaboriaud; Philippe Frachet; Nicole M Thielens; Gérard J Arlaud
Journal:  Front Immunol       Date:  2012-01-06       Impact factor: 7.561

10.  The Surface-Exposed Protein SntA Contributes to Complement Evasion in Zoonotic Streptococcus suis.

Authors:  Simin Deng; Tong Xu; Qiong Fang; Lei Yu; Jiaqi Zhu; Long Chen; Jiahui Liu; Rui Zhou
Journal:  Front Immunol       Date:  2018-05-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.